share_log

MEI Pharma | 8-K: MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

SEC ·  May 10 04:03
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.